Navigation Links
Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel,Anticancer Agents, at AACR

HAYWARD, Calif., April 18, 2007 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated today presented preclinical data on its proprietary nuclear export inhibitors (NEI) showing induction of potent, fast-acting and long-lasting anticancer activity with a high degree of tolerability in multiple human tumor xenograft cancer models.

Kosan's NEIs are potent, specific inhibitors of CRM1, a highly conserved, essential protein that exports key regulatory proteins ("cargo" proteins) from the nucleus to the cytoplasm. Many cargo proteins that depend on CRM1 for nuclear export, such as p53, Bcr-Abl and FOXO-3a, function as tumor suppressors or transcription factors that protect normal cells by regulating cell growth and apoptosis (cell death). Accumulation of these CRM1 cargo proteins in the nucleus, by blocking nuclear export, leads to the inhibition of cell growth and apoptosis selectively in cancer cells. Kosan's polyketide- based NEI compounds have optimized pharmaceutical properties, including potency, durability of action and a wide therapeutic index. Kosan anticipates becoming the first company to advance a nuclear export inhibitor into clinical development.

"We believe that Kosan has established an industry-leading position in NEI technology and has the only NEI inhibitor in late-stage preclinical development," said Pieter B.M.W.M. Timmermans, Ph.D., Kosan's Senior Vice President, Drug Discovery and Preclinical Development. "Our NEIs have demonstrated potent anticancer activity in human tumor xenograft models of breast, cervical, colon and non-small cell lung cancers, melanoma and leukemia, and have been shown to have robust efficacy in vivo at doses that are well-tolerated. We believe that NEIs represent a novel mechanism of action and have the potential to work additively and synergistically with a broad spectrum of cancer chemotherapies such as DNA-damaging agents that have limited durability
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
3. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
4. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
5. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
6. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
7. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference

Post Your Comments:
(Date:11/6/2009)..., Nov. 6 Derma Science...f advanced wound care products, announced plans to...ket on Monday, November 16, 2009. The Company will...he results at 11:00 am EST. Interested parties sho...84 (international), with passcode 81416481 to acce...
(Date:11/6/2009)...., Nov. 6 Philips Respironics appl...l and Prevention (CDC) to raise awareness about an...sufficiency. The CDC,s release of the first-ever g...ces in sleeplessness is a milestone in quantifying...ng-time educator, industry leader and sleep therap...
(Date:11/6/2009)... Cyberonics, Inc. (Nasda...eport financial results for the second quarter end...l 30, 2010 on Wednesday, November 18, 2009 at 5:00...ll to discuss those results on Thursday, November ...Second Quarter Results Conference Call Instruction...
Breaking Medicine Technology:Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 1Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 2Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 3Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 4Abbott Announces New EAS 28R 29 Myoplex 28R 29 Strength Formula Nutrition Shake and Debuts Bottle Packaging 48284 5AssureRx Adds New CEO 12542 1AssureRx Adds New CEO 12542 2How Prepared are Americas Communities to Handle the Aging Boom 3F 48283 1How Prepared are Americas Communities to Handle the Aging Boom 3F 48283 2How Prepared are Americas Communities to Handle the Aging Boom 3F 48283 3How Prepared are Americas Communities to Handle the Aging Boom 3F 48283 4
...Nov. 21 Commenting on a study,of lung transplanta...pediatric pulmonologist calls the study "startling...al of Medicine that accompanies the study., Julia...ndowed Chair in,Pediatric Pulmonary Medicine at Th... study by a University of Utah research team, whic...
...of a new cytokine called IL-35 could allow clinici...mune response, MEMPHIS, Tenn., Nov. 21 Investiga... discovered a new signaling molecule,that prevents...he body. The,finding could lead to the development... autoimmune diseases, such as Type 1 diabetes; and...
Other Medicine Technology:Pediatric Pulmonary Expert Comments on Study of Lung Transplants for Cystic Fibrosis 2St. Jude Finds Molecule That Could Improve Cancer Vaccine and Therapy for Other Diseases 2
(Date:11/7/2009)... Forget ‘sweatox’ or ‘Bo...he usage of the anti-ageing jab ‘Breastox&rs... into the décolletage, can reduce the appea...rea around the breasts, leaving smoother, younger-...ovember 7, 2009 -- Transform, the UK’s large...
(Date:11/6/2009)... TSX: COM , VANCOUVER, Nov. 6 /PRNewswire-FirstCal...COM) today announced that it will report financial... 2009 on the morning of Monday, November 9, 2009. ...st at 9:00am Eastern (6:00am Pacific) on that day ...e call, please dial 416-695-7806 or 888-789-9572 a...
(Date:11/6/2009)..., N.J. and COLUMBUS, Ohio, Nov. 6 Authentidate Ho... of secure Health Information Exchange and workflo... that allows Inscrybe® Healthcare to be easil...eading information systems, Definitive Homecare So...cluded in the CPR+ Integrated Solutions Provider p...
(Date:11/6/2009)...Y., Nov. 6 The Leukemia & Lymphoma Societ...Give & Get program, which in its first two cam...than $1 million to support LLS,s blood cancer rese...vices. ,, During the campaign, taking place from N...adable 30% discount coupons participants can use...
(Date:11/6/2009)...., Nov. 6 Healthcare Trust of America, Inc. (the ...nvestment trust, announced the execution of a Purc...re a medical office building located in Englewood,...ampden Place Medical Center is located within the ...se redevelopment district. Hampden Place is locate...
Breaking Medicine News(10 mins):Health News:UK Boobs Get a Boost with 'Breastox' 2Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 2Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 3Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 4Health News:Get a Jump on Your Holiday Shopping and Give Two Gifts This Season: One to Your Loved Ones and One to People Battling Blood Cancer 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 66,339 SF Medical Office Building Located in Englewood, Colorado 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 66,339 SF Medical Office Building Located in Englewood, Colorado 3
...Call/ - QLT Inc. (NASDAQ: QLTI;,TSX: QLT) announce...d Phase,II study, in patients with subfoveal choro...ated macular degeneration (AMD), showed that a,com...t six months to gain similar visual acuity compare...
...s to try technology like sensors,to detect falls a...pliances, but cost, perception, and technical issu... adults want to,use technology so they can age saf...intain equipment remain barriers for,people 65-plu...
...orporation (NYSE: SYK ) announced that it will ho...t 4:30 p.m., Eastern Time, to discuss the,Company,..., 2008 and,provide an operational update. Operatin...Dean H.,Bergy, Vice President and Chief Financial ...
...ost esteemed scientists is Professor Patrick Tam f...I) who has just been elected as a Fellow of the Au... Frazer and Fiona Stanley are also among only 400 ...team have recently completed a fate map of early e...
...ke Bogda, Timothy Sawyer Promoted; ..., March 28 Barr,Pharmaceuticals, Inc. (NYSE: BRL... management team to better align the Company,s glo...tive,Officer, Bruce L. Downey, announced the follo...
...oration announces a,call for research papers invol...Lock device is designed to promote best practice f...ng contamination of the administration,set when di...acing the need for single-use, sterile caps. Baxa ...
Other Medicine News:Health News:Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference 2Health News:Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference 3Health News:Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference 4Health News:Older People Want to Use Technology to Help Them Remain at Home 2Health News:Older People Want to Use Technology to Help Them Remain at Home 3Health News:Older People Want to Use Technology to Help Them Remain at Home 4Health News:Stryker to Host Conference Call on April 17, 2008 2Health News:National recognition for top scientist 2Health News:Barr Announces Reorganization of Senior Management, Business Functions 2Health News:Barr Announces Reorganization of Senior Management, Business Functions 3Health News:Barr Announces Reorganization of Senior Management, Business Functions 4Health News:Barr Announces Reorganization of Senior Management, Business Functions 5Health News:Barr Announces Reorganization of Senior Management, Business Functions 6Health News:Barr Announces Reorganization of Senior Management, Business Functions 7Health News:Baxa Corporation Launches Call for Research Papers 2
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
... laboratory and a worldwide leader in innovative l... extensive test menu of highly complex and unique ...Owned by the University of Utah, ARUP Laboratories...niversity teaching hospitals and children's hospit...
Medicine Products: